Pump-priming grants

VALIDATE pump-priming grants

**The 2022 call is now closed**

 

The VALIDATE Network aims to accelerate vaccine research and development for complex intracellular pathogens that cause diseases significant to low and middle-income countries (LMIC), with an initial focus on Mycobacterium tuberculosis, Leishmania spp, Burkholderia pseudomallei and Mycobacterium leprae. VALIDATE is proud to partner with the Collaboration for Tuberculosis Vaccine Discovery (CTVD) for our 2022 call (please note this is our only planned pump-priming grant call for the foreseeable future).

 

Pump-priming grants are available for projects of up to £50,000 (plus up to 15% indirect costs) via competitive application to the Network Management Board (NMB). Projects should run for a maximum of 12 months and should lead to relevant and useful data for the field, or produce pilot data that will lead to a larger grant application to an external funder. Projects must be scientifically excellent, and fall within the VALIDATE remit.

 

Please note that for the 2022 pump-priming call, only research focused on tuberculosis vaccine development is eligible. Any aspect of research that will accelerate development of an efficacious TB vaccine is eligible, including biological, physical and social sciences, and humanities.

 

Awards are open to all VALIDATE and CTVD members, but projects must be led by a VALIDATE Associate or CTVD Early Career Researcher. All collaborators must be VALIDATE or CTVD members.

 

We particularly welcome projects including any of the following: new collaborations between VALIDATE and/or CTVD members, projects involving collaborators from more than one institute, projects including Early Career Researchers, projects led by and/or including LMIC partners, projects with industry involvement, cross-discipline research, projects promoting the One Health agenda, in vivo research, and translational research.

 

All awardees will be required to submit narrative and financial progress reports at 6 and 12 months. All awardees must agree to sharing unpublished and published project data set information on the VALIDATE shared data list to accelerate the progression towards development of efficacious vaccines for tuberculosis.

 

Please submit your application form and associated documents as one pdf by 4pm GMT on the closing date to the VALIDATE Network Manager, Samantha Vermaak, at VALIDATE@ndm.ox.ac.uk. All documents must be in English. Please see the further details below about this award and how to apply. Do contact Sam with any further queries.

Q&A Sessions

We will be running two virtual Q&A sessions where you can ask any questions you have about the VALIDATE Pump-priming and Training Grant calls. Please contact Sam if you would like to attend, to be sent the meeting link:

  • 1000 GMT, 6 January 2022
  • 1600 GMT, 11 January 2022

 

Application Documents

List of LMIC countries 

 

Pump-priming grant call deadlines

Round 5 (call open)

Call opens:  7 December 2021

Call closes: 7 March 2022

NMB review meeting: March 2022

Outcomes: April 2022

Please note this is the only planned call unless VALIDATE secures further external funding.

 

Round 4 - awarded

Call opens:  23 July 2019

Call closes: 22 October 2019

NMB review meeting: November 2019

Outcomes: December 2019

 

Round 3 - awarded

Call opens: 29 November 2018

Call closes: 12 February 2019

NMB review meeting: March 2019

Outcomes: April 2019

 

Round 2 - awarded

Call opens: 06 April 2018

Call closes: 14 June 2018

NMB review meeting: July 2018

Outcomes: August 2018

 

Round 1 - awarded

Call opens: 04 October 2017

Call closes: 31 October 2017

NMB review meeting: 08 November 2017

Outcomes: by 22 November 2017

 

Research